Hyper Corporation

Hyper Corporation CROIC

The Cash Return on Invested Capital (CROIC) of Hyper Corporation (065650.KQ) as of Nov 16, 2026 is -57.74 %. In the previous year, Cash Return on Invested Capital (CROIC) was -30.65 % — a change of 88.39% (lower).

CROIC

-57.74 %

YoY

88.39%

Last updated:

Cash Return on Invested Capital (CROIC) of Hyper Corporation is 2025 -57.74 % . Cash Return on Invested Capital (CROIC) of Hyper Corporation was 2024 -30.65 % . It decreases by 88.39% lower compared to the previous year.

The Hyper Corporation CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
-4.54 KRW
Jan 1, 2019
-24.53 KRW
Jan 1, 2020
-8.66 KRW
Jan 1, 2021
-10.81 KRW
Jan 1, 2022
-8.77 KRW
Jan 1, 2023
-6.74 KRW
Jan 1, 2024
-30.65 KRW
Jan 1, 2025
-57.74 KRW
The Hyper Corporation CROIC history
YEARCROICYoY
-57.74 %+88.39%
-30.65 %+354.98%
-6.74 %-23.21%
-8.77 %-18.86%
-10.81 %+24.79%
-8.66 %-64.68%
-24.53 %+440.01%
-4.54 %-5.51%
-4.81 %+4.34%
-4.61 %+724.77%
-0.56 %+431.62%
-0.11 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyper Corporation Stock analysis

What does Hyper Corporation do? Hyper Corporation Inc generates revenue through the Information Technology Business segment, which manufactures and sells mouses, monitors, televisions, routers, and game devices, while also operating Internet portals and specialized sites. The New Drug Business segment develops and sells non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits. The company's IT products are purchased by consumers and businesses seeking technology solutions, while the pharmaceutical products target healthcare providers and patients requiring pain management and cognitive health support. The Information Technology Business segment benefits from the sale of hardware devices and digital content services, with Internet portals and specialized sites driving user engagement and advertising revenue. The New Drug Business segment focuses on medical solutions for chronic conditions, serving both institutional and individual markets through direct sales channels. Both segments operate under the same corporate structure, leveraging the company's existing infrastructure for product development and distribution. Hyper Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyper Corporation stock

Cash Return on Invested Capital (CROIC) of Hyper Corporation is -57.74 % in 2025.

Cash Return on Invested Capital (CROIC) of Hyper Corporation changed from -30.65 % to -57.74 %, representing a 88.39% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Hyper Corporation since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Hyper Corporation with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Hyper Corporation

All Key Metrics — Hyper Corporation